Toxic shock syndrome risk factors: Difference between revisions
Usama Talib (talk | contribs) |
Usama Talib (talk | contribs) |
||
Line 12: | Line 12: | ||
*[[Menstruation]] | *[[Menstruation]] | ||
*Nasal packing | *Nasal packing | ||
* | *Wound infection | ||
*Recent surgery | *Recent surgery | ||
Revision as of 15:46, 30 May 2017
Toxic shock syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Toxic shock syndrome risk factors On the Web |
American Roentgen Ray Society Images of Toxic shock syndrome risk factors |
Risk calculators and risk factors for Toxic shock syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Menstruating women, women using barrier contraceptive devices, persons who have undergone nasal surgery, and persons with postoperative staphylococcal wound infections are the most important risk factors for toxic shock syndrome.
Risk Factors
- Absence of protective immunity
- Parturition
- Infections
- Menstruation
- Nasal packing
- Wound infection
- Recent surgery
Although scientists have recognized an association between toxic shock syndrome (TSS) and tampon use, no firm causal link has been established. Research conducted by the CDC suggested that use of some high absorbency tampons increased the risk of TSS in menstruating women. A few specific tampon designs and high absorbency tampon materials were also found to have some association with increased risk of TSS. These products and materials are no longer used in tampons sold in the U.S. (The materials include polyester, carboxymethylcellulose and polyacrylate).[1] Tampons made with rayon do not appear to have a higher risk of TSS than cotton tampons of similar absorbency.[2]
References
- ↑ Citrinbaum, Joanna (Oct. 14, 2003). "The question's absorbing: 'Are tampons little white lies?'". The Digital Collegian. Retrieved 2006-03-20. Check date values in:
|year=
(help) - ↑ Parsonnet J, Modern P, Giacobbe K (1996). "Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro". J Infect Dis. 173 (1): 98–103. PMID 8537689.